终止上市！600200，周三摘牌！

Core Viewpoint - The company Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (ST Wuzhong) will be delisted from the Shanghai Stock Exchange on December 31, 2025, following a trading period of 15 days after the announcement of its delisting [1][5]. Group 1: Delisting Process - The company's stock will enter a delisting transition period starting December 9, 2025, and will be officially delisted on December 31, 2025 [1]. - After delisting, the company's shares will be transferred to the National Equities Exchange and Quotations (NEEQ) system for trading, managed by a designated broker [2]. Group 2: Financial Misconduct - The company was found to have significant financial discrepancies, including failing to disclose the actual controller and falsifying financial reports from 2018 to 2023 [5]. - The company inflated its operating income and costs, with reported inflated figures of 495.26 million yuan, 468.51 million yuan, 430.75 million yuan, and 376.66 million yuan for the years 2020 to 2023, respectively [6]. - The inflated profits for the same years were reported as 14.58 million yuan, 20.27 million yuan, 19.92 million yuan, and 21.22 million yuan, representing significant percentages of the total reported profits [6]. Group 3: Related Party Transactions - The company engaged in non-commercial trade activities with related parties, leading to significant non-operational fund occupation, which was not disclosed in financial reports from 2020 to 2023 [7]. - The balance of non-operational funds occupied by related parties reached 169.26 million yuan by the end of 2023, constituting 96.09% of the company's net assets [7].